![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | RGD:1316836 | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RASAL2 mRNA | CTD | PMID:24763279 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1316836 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASAL2 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | decreases expression | ISO | RGD:1558084 | 6480464 | ethylene dichloride results in decreased expression of RASAL2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of RASAL2 mRNA | CTD | PMID:27840820 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1558084 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RASAL2 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RASAL2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RASAL2 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of RASAL2 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1316836 | 6480464 | Lactic Acid results in decreased expression of RASAL2 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1558084 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RASAL2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1558084 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased expression of RASAL2 mRNA | CTD | PMID:33297965 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of RASAL2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | RGD:1316836 | 6480464 | Aflatoxin B1 results in decreased methylation of RASAL2 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of RASAL2 mRNA | CTD | PMID:33354967 | aflatoxin M1 | decreases expression | ISO | RGD:1316836 | 6480464 | Aflatoxin M1 results in decreased expression of RASAL2 mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | decreases expression | ISO | RGD:1316836 | 6480464 | Tretinoin results in decreased expression of RASAL2 mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | RGD:1316836 | 6480464 | Antirheumatic Agents results in increased expression of RASAL2 mRNA | CTD | PMID:24449571 | aristolochic acid | decreases expression | ISO | RGD:1316836 | 6480464 | aristolochic acid I results in decreased expression of RASAL2 mRNA | CTD | PMID:33212167 | arsane | affects expression | ISO | RGD:1316836 | 6480464 | Arsenic affects the expression of RASAL2 mRNA | CTD | PMID:18414638 | arsane | affects methylation | ISO | RGD:1316836 | 6480464 | Arsenic affects the methylation of RASAL2 gene | CTD | PMID:25304211 | arsenic atom | affects expression | ISO | RGD:1316836 | 6480464 | Arsenic affects the expression of RASAL2 mRNA | CTD | PMID:18414638 | arsenic atom | affects methylation | ISO | RGD:1316836 | 6480464 | Arsenic affects the methylation of RASAL2 gene | CTD | PMID:25304211 | benzo[a]pyrene | decreases expression | ISO | RGD:1558084 | 6480464 | Benzo(a)pyrene results in decreased expression of RASAL2 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | affects methylation | ISO | RGD:1316836 | 6480464 | Benzo(a)pyrene affects the methylation of RASAL2 intron | CTD | PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | RGD:1316836 | 6480464 | Benzo(a)pyrene results in decreased expression of RASAL2 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1316836 | 6480464 | 7 more ... | CTD | PMID:19150397, PMID:20018196 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RASAL2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | RGD:1316836 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RASAL2 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | ISO | RGD:1316836 | 6480464 | bisphenol A results in increased methylation of RASAL2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of RASAL2 mRNA | CTD | PMID:31129395 | bisphenol A | increases expression | ISO | RGD:1558084 | 6480464 | bisphenol A results in increased expression of RASAL2 mRNA | CTD | PMID:25594700 | bisphenol F | multiple interactions | ISO | RGD:1316836 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of RASAL2 gene | CTD | PMID:31601247 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of RASAL2 mRNA | CTD | PMID:33453195 | cadmium dichloride | increases expression | ISO | RGD:1316836 | 6480464 | Cadmium Chloride results in increased expression of RASAL2 mRNA | CTD | PMID:26472689 | cisplatin | decreases expression | ISO | RGD:1316836 | 6480464 | Cisplatin results in decreased expression of RASAL2 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | RGD:1316836 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of RASAL2 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | RGD:1316836 | 6480464 | Copper Sulfate results in increased expression of RASAL2 mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | ISO | RGD:1316836 | 6480464 | Asbestos, Crocidolite results in increased expression of RASAL2 mRNA | CTD | PMID:18687144 | crocidolite asbestos | decreases expression | ISO | RGD:1558084 | 6480464 | Asbestos, Crocidolite results in decreased expression of RASAL2 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | RGD:1558084 | 6480464 | Cyclosporine results in decreased expression of RASAL2 mRNA | CTD | PMID:25270620 | cyclosporin A | increases expression | ISO | RGD:1316836 | 6480464 | Cyclosporine results in increased expression of RASAL2 mRNA | CTD | PMID:25562108 | cylindrospermopsin | increases expression | ISO | RGD:1316836 | 6480464 | cylindrospermopsin results in increased expression of RASAL2 mRNA | CTD | PMID:24921660 | doxorubicin | decreases expression | ISO | RGD:1316836 | 6480464 | Doxorubicin results in decreased expression of RASAL2 mRNA | CTD | PMID:29803840 | fulvestrant | multiple interactions | ISO | RGD:1316836 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RASAL2 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of RASAL2 gene | CTD | PMID:31601247 | glyphosate | increases expression | ISO | RGD:1316836 | 6480464 | glyphosate results in increased expression of RASAL2 mRNA | CTD | PMID:31295307 | glyphosate | decreases expression | ISO | RGD:1316836 | 6480464 | glyphosate results in decreased expression of RASAL2 mRNA | CTD | PMID:31295307 | hydrogen peroxide | decreases expression | ISO | RGD:1316836 | 6480464 | Hydrogen Peroxide results in decreased expression of RASAL2 mRNA | CTD | PMID:18951874 | methyl methanesulfonate | increases expression | ISO | RGD:1316836 | 6480464 | Methyl Methanesulfonate results in increased expression of RASAL2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | RGD:1316836 | 6480464 | methylmercuric chloride results in increased expression of RASAL2 mRNA | CTD | PMID:23179753, PMID:28001369 | methylmercury chloride | decreases expression | ISO | RGD:1316836 | 6480464 | methylmercuric chloride results in decreased expression of RASAL2 mRNA | CTD | PMID:28001369 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RASAL2 mRNA | CTD | PMID:33387578 | phenobarbital | affects expression | ISO | RGD:1316836 | 6480464 | Phenobarbital affects the expression of RASAL2 mRNA | CTD | PMID:19159669 | pirinixic acid | multiple interactions | ISO | RGD:1558084 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RASAL2 mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | ISO | RGD:1316836 | 6480464 | potassium chromate(VI) results in decreased expression of RASAL2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1316836 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASAL2 mRNA | CTD | PMID:22079256 | rac-lactic acid | decreases expression | ISO | RGD:1316836 | 6480464 | Lactic Acid results in decreased expression of RASAL2 mRNA | CTD | PMID:30851411 | silver atom | increases expression | ISO | RGD:1316836 | 6480464 | Silver results in increased expression of RASAL2 mRNA | CTD | PMID:26014281 | silver(0) | increases expression | ISO | RGD:1316836 | 6480464 | Silver results in increased expression of RASAL2 mRNA | CTD | PMID:26014281 | simazine | increases expression | ISO | RGD:1558084 | 6480464 | Simazine results in increased expression of RASAL2 mRNA | CTD | PMID:22984576 | sodium arsenate | decreases expression | ISO | RGD:1558084 | 6480464 | sodium arsenate results in decreased expression of RASAL2 mRNA | CTD | PMID:21795629 | sodium arsenate | increases expression | ISO | RGD:1558084 | 6480464 | sodium arsenate results in increased expression of RASAL2 mRNA | CTD | PMID:21795629 | tebuconazole | decreases expression | ISO | RGD:1316836 | 6480464 | tebuconazole results in decreased expression of RASAL2 mRNA | CTD | PMID:30458266 | theophylline | decreases expression | ISO | RGD:1316836 | 6480464 | Theophylline results in decreased expression of RASAL2 mRNA | CTD | PMID:18951874 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of RASAL2 mRNA | CTD | PMID:31129395 | trichostatin A | increases expression | ISO | RGD:1316836 | 6480464 | trichostatin A results in increased expression of RASAL2 mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | RGD:1316836 | 6480464 | trichostatin A affects the expression of RASAL2 mRNA | CTD | PMID:28542535 | valproic acid | affects expression | ISO | RGD:1316836 | 6480464 | Valproic Acid affects the expression of RASAL2 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of RASAL2 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | ISO | RGD:1316836 | 6480464 | Valproic Acid results in decreased expression of RASAL2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:1316836 | 6480464 | Valproic Acid results in increased expression of RASAL2 mRNA | CTD | PMID:19101580 more ... | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RASAL2 mRNA | CTD | PMID:23034163 | |